HCA Healthcare Stock Price Hits All-Time High as Earnings Top Estimates

Core Insights - HCA Healthcare reported increased patient usage of its facilities, leading to sales and profits exceeding forecasts for the second quarter [1][4] - The company raised its full-year adjusted earnings per share (EPS) and revenue guidance [2][8] Financial Performance - HCA Healthcare's second-quarter adjusted EPS was $5.53, surpassing the analyst estimate of $4.86 [7] - Revenue increased by 10.3% to $17.49 billion, also above expectations [7] Patient Metrics - Same-facility admissions rose by 5.8% year-on-year [5] - Same-facility emergency room visits increased by 5.5% [5] - Same-facility inpatient surgeries grew by 2.6% [5] - However, same-facility outpatient surgeries declined by 2.1% [5] Guidance Update - The company raised its full-year adjusted EPS outlook to a range of $21.60 to $22.80, up from $19.70 to $21.20 [8] - Revenue guidance for the year was increased to $69.75 billion to $71.75 billion, up from $67.75 billion to $70.25 billion [8] Stock Performance - HCA Healthcare shares rose by 4.2% to $338.95 in late trading, reaching an intraday high of $348.00 [3] - The stock's record closing high was $343.29, recorded in late June [3]